Follow
Dr. Prasanna K. Santhekadur
Dr. Prasanna K. Santhekadur
Associate Professor/ Ramalingaswami Fellow, Department of Biochemistry, Center of Excelence in
Verified email at jssuni.edu.in - Homepage
Title
Cited by
Cited by
Year
The Presence and Severity of Nonalcoholic Steatohepatitis is Associated With Specific Changes in Circulating Bile Acids.
Puri P., Daita K., Joyce A., Mirshahi F, Santhekadur PK., Cazanave S ...
Hepatology, 2017
349*2017
Preclinical models of non-alcoholic fatty liver disease
PK Santhekadur, DP Kumar, AJ Sanyal
Journal of hepatology 68 (2), 230-237, 2018
3332018
Increased RNA‐induced silencing complex (RISC) activity contributes to hepatocellular carcinoma
Yoo BK, Santhekadur,PK, R Gredler, D Chen, L Emdad, S Bhutia, ...
Hepatology 53 (5), 1538-1548, 2011
2122011
Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology
Yoo BK, L Emdad, SG Lee, Z Su, P Santhekadur, D Chen, R Gredler, ...
Pharmacology & therapeutics 130 (1), 1-8, 2011
2012011
Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves …
PK Santhekadur, SK Das, R Gredler, D Chen, J Srivastava, C Robertson, ...
Journal of Biological Chemistry 287 (17), 13952-13958, 2012
1632012
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer
S Rajput, BNP Kumar, S Sarkar, S Das, B Azab, PK Santhekadur, SK Das, ...
PloS one 8 (4), e61342, 2013
1372013
Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness
L Emdad, A Janjic, MA Alzubi, B Hu, PK Santhekadur, ME Menezes, ...
Neuro-oncology 17 (3), 419-429, 2015
1112015
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux, Prasanna K ...
Scientific Reports, 2020
1062020
Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
Chen D, BK Yoo, PK Santhekadur, R Gredler, SK Bhutia, SK Das, C Fuller, ...
Clinical Cancer Research 17 (21), 6693-6701, 2011
1062011
MDA-9/Syntenin and IGFBP-2 Promote Angiogenesis in Human Melanoma
SK Das, S k Bhutia, B Azab, TP Kegelman, L Peachy, PK Santhekadur, ...
Cancer Research, 2012
1002012
Astrocyte elevated gene‐1 (AEG‐1) promotes hepatocarcinogenesis: Novel insights from a mouse model
J Srivastava, A Siddiq, L Emdad, PK Santhekadur, D Chen, R Gredler, ...
Hepatology, 2012
982012
Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling
PK Santhekadur, M Akiel, L Emdad, R Gredler, J Srivastava, ...
FEBS open bio 4, 353-361, 2014
862014
The multifaceted role of natriuretic peptides in metabolic syndrome
Santhekadur PK, Divya P. Kumar, Mulugeta Seneshaw, Faridoddin Mirshahi, Arun ...
Biomedicine & Pharmacotherapy 92, 826–835, 2017
762017
The transcription factor LSF: a novel oncogene for hepatocellular carcinoma
PK Santhekadur, D Rajasekaran, A Siddiq, R Gredler, D Chen, ...
American journal of cancer research 2 (3), 269, 2012
692012
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.
CS Podtelezhnikov A, Jensen K, Seneshaw M, Kumar DP, Min HK, Santhekadur PK ...
Sci Rep. 7 (1), 1-3, 2017
60*2017
Extracellular vesicles as inflammatory drivers in NAFLD
AN Srinivas, D Suresh, PK Santhekadur, D Suvarna, DP Kumar
Frontiers in immunology 11, 627424, 2021
542021
Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)
PK Santhekadur, R Gredler, D Chen, A Siddiq, XN Shen, SK Das, ...
Journal of Biological Chemistry 287 (5), 3425-3432, 2012
452012
A regulatory role of apoptosis antagonizing transcription factor in the pathogenesis of nonalcoholic fatty liver disease and hepatocellular carcinoma
DP Kumar, PK Santhekadur, M Seneshaw, F Mirshahi, ...
Hepatology 69 (4), 1520-1534, 2019
442019
c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF
Yoo BK, R Gredler, C Dong, PK Santhekadur, PB Fisher, D Sarkar
Journal of hepatology, 2011
442011
Withaferin A suppresses the expression of vascular endothelial growth factor in Ehrlich ascites tumor cells via Sp1 transcription factor
S Prasanna Kumar, P Shilpa, BP Salimath
http://www.pharmainfo.net/articles/withaferin-suppresses-expression-vascular …, 2009
332009
The system can't perform the operation now. Try again later.
Articles 1–20